Proprietary AI analyst is now available
- Public Comps
- Delko
Delko Valuation Multiples
Discover revenue and EBITDA valuation multiples for Delko and similar public comparables like Promisia Healthcare, EZZ Life Science, Natural Health Trends, Cosma and more.
Delko Overview
About Delko
Delko SA is engaged in the wholesale distribution of household chemistry products, cosmetics and personal care products in Poland.
Founded
1995
HQ

Employees
897
Website
Sectors
Financials (FY)
EV
$41M
Valuation Multiples
Start free trialDelko Financials
Delko reported last fiscal year revenue of $213M and EBITDA of $7M.
In the same fiscal year, Delko generated $47M in gross profit, $7M in EBITDA, and $789K in net income.
Delko P&L
In the most recent fiscal year, Delko reported revenue of $213M and EBITDA of $7M.
Delko is profitable as of last fiscal year, with gross margin of 22%, EBITDA margin of 3%, and net margin of 0%.
Financial data powered by Morningstar, Inc.
Delko Stock Performance
Delko has current market cap of $19M, and enterprise value of $41M.
Market Cap Evolution
Delko's stock price is $1.61.
Delko share price decreased by 2.6% in the last 30 days, and by 11.4% in the last year.
Delko has an EPS (earnings per share) of $0.07.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $41M | $19M | 0.0% | -2.6% | -6.9% | -11.4% | $0.07 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialDelko Valuation Multiples
Delko trades at 0.2x EV/Revenue multiple, and 5.6x EV/EBITDA.
Delko Financial Valuation Multiples
As of June 14, 2026, Delko has market cap of $19M and EV of $41M.
Delko has a P/E ratio of 24.4x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Delko Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Delko Margins & Growth Rates
In the most recent fiscal year, Delko reported gross margin of 22%, EBITDA margin of 3%, and net margin of 0%.
Delko Margins
Delko Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Delko Operational KPIs
Delko's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
Delko Competitors
Delko competitors include Promisia Healthcare, EZZ Life Science, Natural Health Trends, Cosma, Big Tree Cloud Holdings, Skin Elements, Mediterra, Lavena - Shumen, Clemondo Group and 4Mass.
Most Delko public comparables operate across Health & Beauty and Home Care.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 4.4x | - | 9.2x | - | |||
| 0.2x | 0.2x | 1.1x | - | |||
| (0.0x) | - | 0.6x | - | |||
| 3.6x | - | (20.9x) | - | |||
| 8.3x | - | (0.7x) | - | |||
| 36.8x | - | (10.6x) | - | |||
| - | - | - | - | |||
| 0.8x | - | 5.2x | - | |||
This data is available for Pro users. Sign up to see all Delko competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Delko
| When was Delko founded? | Delko was founded in 1995. |
| Where is Delko headquartered? | Delko is headquartered in Poland. |
| How many employees does Delko have? | As of today, Delko has over 897 employees. |
| Is Delko publicly listed? | Yes, Delko is a public company listed on Warsaw Stock Exchange. |
| What is the stock symbol of Delko? | Delko trades under DEL ticker. |
| When did Delko go public? | Delko went public in 2009. |
| Who are competitors of Delko? | Delko main competitors include Promisia Healthcare, EZZ Life Science, Natural Health Trends, Cosma, Big Tree Cloud Holdings, Skin Elements, Mediterra, Lavena - Shumen, Clemondo Group, 4Mass. |
| What is the current market cap of Delko? | Delko's current market cap is $19M. |
| What is the current revenue of Delko? | Delko's last fiscal year revenue is $213M. |
| What is the current EV/Revenue multiple of Delko? | Current revenue multiple of Delko is 0.2x. |
| Is Delko profitable? | No, Delko is not profitable. |
| How many companies Delko has acquired to date? | Delko hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Delko has invested to date? | Delko hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Delko
Lists including Delko
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.